The breast lesion localization methods market refers to the various techniques and devices used to locate and mark breast lesions prior to surgery. These methods include wire localization, radioisotope localization, magnetic seed localization, and other emerging techniques.
The average age of the patient, the length of the treatment, its success, the expense of the operation, its safety, and its ease of use are all important considerations for the surgeon when selecting the best localization technique.
In 2022, the market for breast lesion localization methods was worth USD 1.02 billion, and by 2030 it will be worth USD 2.47 billion, growing at a 11.68% CAGR during the forecast period.
The breast lesion localization methods market will experience significant growth primarily due to an increasing incidence of breast cancer and the rising adoption of breast cancer screening programs. Additionally, advancements in imaging technologies and the development of more precise and efficient localization techniques will further fuel market growth.
Numerous factors, such as the rising prevalence of breast enlargements among women and the increasing use of contraceptive pills, contribute to developing breast lesions. Furthermore, the market is growing due to the increased occurrence of breast illnesses such as breast cancer and cysts.
The rising incidence of breast cancer, expansion of breast cancer surgeries, expanded government & non-government payment schemes, and rising public awareness of breast cancer diagnoses all contribute to the market’s rise.
The exorbitant expenses of cutting-edge gadgets, the strict regulations governing product clearance procedures, and a shortage of oncologists and qualified specialists in many emerging countries are all impeding the global market. Additionally, the regulatory issues with breast localization and defective products may restrict market expansion.
There are ample opportunities for market participants as a result of aggressive government investment in the development and modernization of healthcare infrastructure. Additionally, the market has favourable growth prospects due to ongoing technological developments and a growing public understanding of breast cancer detection.
By Type of Technique
The mammography guided localization segment ruled the entire market with a revenue share of nearly 70% because of its low cost and higher accuracy rate. To find the lesion within the breast tissue, X-ray imaging is used. Small, early-stage lesions that are not evident on physical inspection are frequently treated with it. Around 20% of breast lesions are located using ultrasound-guided localization, which is a frequent technique, especially for lesions that are challenging to detect using mammography alone.
Due to its high sensitivity and capacity to identify small lesions that may not be evident in other imaging modalities, magnetic resonance imaging (MRI)-guided localization is growing in popularity and accounts for around 5% of breast lesion localizations.
By Type of Procedure
Lumpectomy is the largest market segment with a significant revenue share. The most frequent technique, particularly for breast cancer in its early stages, is a lumpectomy, which entails the removal of only the malignant tissue and some surrounding good tissue. Per the American Society of Breast Surgeons, nearly 50% of breast cancer surgeries involve breast-conserving or minimally invasive lumpectomies. Using breast lesion localization techniques, biopsies are another frequent treatment. In a breast lesion, it is typically utilized to confirm the presence of malignant or precancerous cells.
Hospitals are the leading market segment, with 75% of the revenue share due to a large number of patients treated in hospitals. The diagnostic imaging sector is also a significant end-user as they frequently use imaging techniques to find breast lesions. 20% of all procedures are performed in diagnostic imaging centers. Ambulatory surgery clinics are becoming increasingly popular for breast lesion localization operations due to low cost and faster recovery period.
Nearly 80% of the market was occupied by the wire localization segment due to low cost and simplicity of use. The use of radioactive seed localization devices, especially for tiny, harder-to-find lesions, is growing in popularity and makes up around 15% of all treatments. D, magnetic tracers are becoming more common due to their excellent sensitivity and ability to identify even tiny lesions.
North America accounts for 45% of the entire regional market due to the high frequency of breast cancer and high levels of healthcare spending in this region. Europe makes up around 35% of the worldwide market share, especially in nations like France, Germany, and the United Kingdom. Asia Pacific holds a market share of nearly 15%. Due to rising breast cancer awareness and improved healthcare infrastructure in nations like China and India, Asia Pacific will witness rapid expansion in the upcoming years.
Tsunami Medical S.r.l.
Cook Medical LLC
C.R. Bard, Inc. (a subsidiary of Becton, Dickinson, and Company)
CP Medical, Inc.
Argon Medical Devices, Inc.
SOMATEX Medical Technologies GmbH
INTRAMEDICAL IMAGING LLC
STI Laser Industries Ltd.
In 2022, the market for breast lesion localization methods was worth USD 1.02 billion, and by 2030 it will be worth USD 2.47 billion, growing at a 11.68% CAGR during the forecast period. The rising prevalence of breast cancer is the main element driving the market’s expansion.
Robotic Process Automation Market Report – The global robotic process automation market will witness a robust CAGR of 27%, valued at $3.05 Billion in 2021, and expected to appreciate and reach $4.4 Billion in 2022 and $24 Billion by 2030, confirms Strategic Market Research.